{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T02:45:42Z","timestamp":1785725142766,"version":"3.56.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.canlet.2026.218702","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:57:30Z","timestamp":1783090650000},"page":"218702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunotherapy-based combination remodels the immunosuppressive microenvironment and enhances efficacy in advanced SMARCA4-deficient non-small cell lung cancer"],"prefix":"10.1016","volume":"657","author":[{"given":"Sixuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7650-6727","authenticated-orcid":false,"given":"Linling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangzhou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muqun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4189-9692","authenticated-orcid":false,"given":"Yiquan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218702_bib1","doi-asserted-by":"crossref","first-page":"eabq2403","DOI":"10.1126\/sciadv.abq2403","article-title":"POU2AF2\/C11orf53 functions as a coactivator of POU2F3 by maintaining chromatin accessibility and enhancer activity","volume":"8","author":"Szczepanski","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218702_bib2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.7150\/thno.63627","article-title":"\u03b1-Catulin promotes cancer stemness by antagonizing WWP1-mediated KLF5 degradation in lung cancer","volume":"12","author":"Tung","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2026.218702_bib3","doi-asserted-by":"crossref","first-page":"14171","DOI":"10.1002\/cam4.6083","article-title":"Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer","volume":"12","author":"Liang","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2026.218702_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.anndiagpath.2016.10.006","article-title":"SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens","volume":"26","author":"Herpel","year":"2017","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.canlet.2026.218702_bib5","first-page":"103506","article-title":"Neoadjuvant immunochemotherapy in resectable NSCLC with SMARCA4 alterations","author":"Peng","year":"2025","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.canlet.2026.218702_bib6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1158\/2159-8290.CD-21-0248","article-title":"Smarca4 inactivation promotes lineage-specific transformation and early metastatic features in the lung","volume":"12","author":"Concepcion","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218702_bib7","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ccell.2023.03.018","article-title":"Genomic mapping of metastatic organotropism in lung adenocarcinoma","volume":"41","author":"Lengel","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218702_bib8","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jtho.2020.01.002","article-title":"Clinicopathologic characteristics of BRG1-Deficient NSCLC","volume":"15","author":"Dagogo-Jack","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.canlet.2026.218702_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/PAS.0000000000001188","article-title":"SMARCA4-deficient thoracic sarcomas: clinicopathologic study of 30 cases with an emphasis on their nosology and differential diagnoses","volume":"43","author":"Perret","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2026.218702_bib10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12105-022-01416-x","article-title":"Proceedings of the north American Society of head and neck pathology, Los Angeles, CA, March 20, 2022: swi\/snf-deficient sinonasal neoplasms: an overview","volume":"16","author":"Agaimy","year":"2022","journal-title":"Head Neck Pathol."},{"key":"10.1016\/j.canlet.2026.218702_bib11","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1158\/1535-7163.MCT-21-0433","article-title":"SMARCA4: implications of an altered chromatin-remodeling gene for cancer development and therapy","volume":"20","author":"Mardinian","year":"2021","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2026.218702_bib12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of Lung Tumors: impact of Advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.canlet.2026.218702_bib13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/jcp-2024-209619","article-title":"Unravelling switch\/sucrose non-fermentable (SWI-SNF) complex-deficient thoracic tumours: a clinicopathological comparative on undifferentiated tumours and non-small cell lung carcinomas with BRG1 and BRM deficiency","volume":"78","author":"Sood","year":"2025","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.canlet.2026.218702_bib14","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1158\/1078-0432.CCR-20-1825","article-title":"The genomic landscape of SMARCA4 alterations and associations with outcomes in patients with lung cancer","volume":"26","author":"Schoenfeld","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218702_bib15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11684-024-1118-y","article-title":"Non small cell lung cancer with SMARCA4 deficiency harboring rare EGFR mutations exhibited significant tumor response when treated with afatinib: a case report","volume":"19","author":"Qiu","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.canlet.2026.218702_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217282","article-title":"SMARCA4 and SMARCA2 co-deficiency: an uncommon molecular signature defining a subset of rare, aggressive and undifferentiated malignancies associated with defective chromatin remodeling","volume":"605","author":"Field","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218702_bib17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41467-019-08380-1","article-title":"SMARCA4 loss is synthetic lethal with CDK4\/6 inhibition in non-small cell lung cancer","volume":"10","author":"Xue","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218702_bib18","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/cncy.22581","article-title":"Cytomorphologic features of SMARCA4-deficient non-small cell lung carcinoma and correlation with immunohistochemical and molecular features","volume":"130","author":"Sun","year":"2022","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.canlet.2026.218702_bib19","first-page":"10","article-title":"Perspectives and issues in the assessment of SMARCA4 deficiency in the management of lung cancer patients","author":"Armon","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218702_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216022","article-title":"SMARCA4: current status and future perspectives in non-small-cell lung cancer","volume":"554","author":"Tian","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218702_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf266","article-title":"Clinicopathological and molecular characteristics and treatment outcomes of SMARCA4-deficient thoracic tumors: a comprehensive analysis","volume":"30","author":"Liu","year":"2025","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2026.218702_bib22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/CAD.0000000000001758","article-title":"Pembrolizumab treatment in SMARCA4-deficient nonsmall cell lung cancer: high tumor mutational burden and programmed death-ligand 1(+) expression on circulating tumor cells for real-time monitoring: a case report","volume":"36","author":"Deng","year":"2025","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.canlet.2026.218702_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1131448","article-title":"Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab","volume":"14","author":"Lin","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218702_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13000-023-01347-3","article-title":"Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma","volume":"18","author":"Gao","year":"2023","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.canlet.2026.218702_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.7150\/thno.79367","article-title":"Blockade of dual immune checkpoint inhibitory signals with a CD47\/PD-L1 bispecific antibody for cancer treatment","volume":"13","author":"Wang","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2026.218702_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk4851","article-title":"Interferon response and epigenetic modulation by SMARCA4 mutations drive ovarian tumor immunogenicity","volume":"10","author":"Brodeur","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218702_bib27","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1158\/0008-5472.CAN-24-2054","article-title":"Mutation of SMARCA4 induces cancer cell-intrinsic defects in the enhancer landscape and resistance to immunotherapy","volume":"85","author":"Wang","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218702_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.canlet.2026.218702_bib29","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218702_bib30","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218702_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/carcin\/bgp035","article-title":"BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer","volume":"30","author":"Rodriguez-Nieto","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2026.218702_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.762598","article-title":"A pan-cancer analysis of SMARCA4 alterations in human cancers","volume":"12","author":"Peng","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218702_bib33","first-page":"15","article-title":"Cancer cell-intrinsic alterations associated with an immunosuppressive tumor microenvironment and resistance to immunotherapy in lung cancer","author":"Otegui","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218702_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.108022","article-title":"Effective treatment strategies and key factors influencing therapeutic efficacy in advanced SMARCA4-deficient non-small cell lung cancer","volume":"198","author":"Liu","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2026.218702_bib35","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1177\/09287329241296242","article-title":"Clinical characteristics and prognostic analysis of patients with SMARCA4-deficient lung cancer","volume":"33","author":"Xu","year":"2025","journal-title":"Technol. Health Care"},{"key":"10.1016\/j.canlet.2026.218702_bib36","first-page":"659","article-title":"[Evaluation of Efficacy and Prognosis Analysis of Stage III-IV SMARCA4-deficient Non-small Cell Lung Cancer Treated by PD-1 Immune Checkpoint Inhibitors plus Chemotherapy and Chemotherapy]","volume":"26","author":"Wang","year":"2023","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"10.1016\/j.canlet.2026.218702_bib37","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1056\/NEJMoa1716948","article-title":"Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC","volume":"378","author":"Socinski","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218702_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/biom14080987","article-title":"The potential of immunotherapy for SMARCA4-Deficient Undifferentiated Uterine Sarcoma (SDUS)","volume":"14","author":"Yao","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.canlet.2026.218702_bib39","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7150\/ijbs.38414","article-title":"Tumor cell-associated exosomes robustly elicit anti-tumor immune responses through modulating dendritic cell vaccines in lung tumor","volume":"16","author":"Wang","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2026.218702_bib40","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/1878-0261.13201","article-title":"DCZ0415, a small-molecule inhibitor targeting TRIP13, inhibits EMT and metastasis via inactivation of the FGFR4\/STAT3 axis and the Wnt\/\u03b2-catenin pathway in colorectal cancer","volume":"16","author":"Agarwal","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.canlet.2026.218702_bib41","first-page":"2428","article-title":"The curative effect of Shenfu-injection in the treatment of burn sepsis and its effect on the patient's immune function, HMGB, and vWF","volume":"14","author":"Xu","year":"2022","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.canlet.2026.218702_bib42","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1038\/s41467-020-18731-y","article-title":"HIF-2\u03b1 is indispensable for regulatory T cell function","volume":"11","author":"Hsu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218702_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cmet.2018.09.020","article-title":"TLR8-Mediated metabolic control of human treg function: a mechanistic target for cancer immunotherapy","volume":"29","author":"Li","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2026.218702_bib44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/cei\/uxac118","article-title":"The potential for Treg-enhancing therapies in transplantation","volume":"211","author":"Steiner","year":"2023","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.canlet.2026.218702_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101425","article-title":"Risk of hepatitis B virus reactivation following treatment with abatacept: a retrospective study of international pharmacovigilance databases","volume":"48","author":"Wang","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.canlet.2026.218702_bib46","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2026019","article-title":"Spatial immune heterogeneity of hypoxia-induced exhausted features in high-grade glioma","volume":"11","author":"Kim","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.canlet.2026.218702_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6440419","article-title":"Immunotherapy and antivascular targeted therapy in patients' treatment with concurrent malignant tumors after organ transplantation: opportunity or challenge","volume":"2022","author":"Shen","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.canlet.2026.218702_bib48","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218702_bib49","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.21037\/tlcr-2025-556","article-title":"Potential efficacy of anti-angiogenic therapy combined with immunotherapy for advanced SMARCA4-deficient thoracic tumor: a retrospective study","volume":"14","author":"Liu","year":"2025","journal-title":"Transl. Lung Cancer Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526004660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526004660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T02:20:27Z","timestamp":1785723627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526004660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":49,"alternative-id":["S0304383526004660"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218702","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunotherapy-based combination remodels the immunosuppressive microenvironment and enhances efficacy in advanced SMARCA4-deficient non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218702"}}